Regeneron opens antibody trial with UTHSC, Regional One
The treatment is expected to shorten the illness in those who are sick and build immunity in those who are not.
There are 1 article(s) tagged REGN-COV2:
The treatment is expected to shorten the illness in those who are sick and build immunity in those who are not.
About 1 results